Quote | Biodesix Inc. (NASDAQ:BDSX)
Last: | $1.25 |
---|---|
Change Percent: | 0.0% |
Open: | $1.25 |
Close: | $1.25 |
High: | $1.25 |
Low: | $1.21 |
Volume: | 47,653 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Biodesix Inc. (NASDAQ:BDSX)
Studies highlight advancements in technology to detect cell-free DNA and rapid turnaround time in a real-world clinical setting Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data was presented at the Americ...
2024-04-05 07:33:29 ET More on Biodesix Biodesix, Inc. (BDSX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Biodesix Read the full article on Seeking Alpha For further details see: Biodesix prices its 17.4M shares offering at $1....
Message Board Posts | Biodesix Inc. (NASDAQ:BDSX)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $BDSX 47% v1,3M c2.00 f81,7M H2.00 ML.97 off 10dma @1.3 | znewcar1 | investorshangout | 11/30/2022 10:29:28 PM |
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE | 1hot toddy | investorshub | 11/22/2022 2:02:28 PM |
Lots if potential but will public offering dilute price? | Leg58 | investorshub | 11/20/2022 5:13:49 AM |
Lots if potential but will public offering dilute price? | Leg58 | investorshub | 11/20/2022 5:13:45 AM |
znewcar1: $BDSX 23% v1,9M c1.42 f42,1M H1.44 ML.96 YL1.07 | znewcar1 | investorshangout | 11/18/2022 5:03:23 AM |
News, Short Squeeze, Breakout and More Instantly...
Biodesix Inc. Company Name:
BDSX Stock Symbol:
NASDAQ Market:
Studies highlight advancements in technology to detect cell-free DNA and rapid turnaround time in a real-world clinical setting Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data was presented at the Americ...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.89% to 3...
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-q...